Sara Khaleel

Dr. Sara Khaleel


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 May 2026 in Molecules
Verified
Journal Article
Open access
PDF file
AAAhmed S.A. Ali Agha
Ahmed S.A. Ali Agha
SKSara Khaleel
Sara Khaleel
HAHamada M. A. Abdelaziz
Hamada M. A. Abdelaziz
MAMuhammad Alzweiri
Muhammad Alzweiri
NQNidal Qinna
Nidal Qinna
TATalal Ahmad Aburjai
Talal Ahmad Aburjai
Aluminum chloride (AlCl3) is widely used in experimental toxicology, particularly in rodent models of neurodegeneration, where its effects have been studied primarily in the central nervous system. However, experimental findings also indicate that chronic exposure is associated with changes across multiple peripheral organs, although these observations are often considered separately. In this review, we bring together evidence from different organ systems to examine aluminum toxicity from a broader perspective. Rather than focusing on isolated tissue-specific effects, we consider the extent to which reported findings may reflect overlapping molecular disturbances expressed across physiological systems. Within this context, organ-level outcomes are discussed as potentially related manifestations of shared underlying processes, while acknowledging variability in experimental conditions and model interpretation. To structure this synthesis, we outline a conceptual framework that links recurring molecular responses, system-level regulatory influences, and tissue-specific patterns of injury. This approach is intended to provide a more integrated way of organizing existing data rather than to establish a single unifying mechanism. Importantly, the pathological alterations discussed throughout this review are interpreted as experimentally observed toxicological manifestations of chronic AlCl3 exposure rather than evidence that aluminum constitutes a definitive etiological cause of Alzheimer’s disease. Overall, this review aims to complement existing neuro-focused interpretations of the AlCl3 model by situating it within a multi-organ context and highlighting areas where further integrative investigation may be warranted.

16 April 2026 in Biology
Verified
Journal Article
Open access
PDF file
AAAhmed S.A. Ali Agha
Ahmed S.A. Ali Agha
SKSara Khaleel
Sara Khaleel
NQNidal Qinna
Nidal Qinna
MAMuhammad Alzweiri
Muhammad Alzweiri
GAGhayda' Aldabet
Ghayda' Aldabet
TATalal Ahmad Aburjai
Talal Ahmad Aburjai
Individual variability in spontaneous behavior emerges from coordinated physiological states, yet the organization of baseline behavioral dimensions and their systemic metabolic correlations remains insufficiently characterized in healthy animals. Here, exploratory activity and self-directed grooming were quantified during a standardized Y-maze session and integrated with plasma fatty-acid profiles measured by orthogonal dual-column GC-MS in 30 healthy male Sprague–Dawley rats distributed across four independent cohorts. Correlation structure and principal component analysis showed that plasma lipid profiles exhibit non-random, low-dimensional organization, resolving into coherent compositional states dominated by coordinated shifts between shorter-chain (C14–C16) and longer-chain (C18) fatty-acid species. Behavioral variables are similarly organized into constrained dimensions capturing exploratory engagement and grooming expression or timing. Integrated correlation analysis indicated that plasma fatty-acid-derived lipid states aligned systematically with behavioral organization at the multivariate level across cohorts, with C18-enriched profiles generally aligned with higher behavioral engagement and earlier grooming expression at the state level, while C14/C16-enriched profiles associated with reduced exploration and delayed grooming initiation, although the direction of individual lipid–behavior correlations showed cohort dependence consistent with the context-dependent behavior of compositional lipid variables within distinct but physiologically normal lipidomic states. These findings demonstrate that state-level, correlation-based multivariate analysis can reveal structured plasma lipidomic configurations and their correspondence to behavioral organization under physiological conditions, without inferring causal directionality or pathway activation.

18 May 2026 in Plants
Verified
Journal Article
Open access
PDF file
SKSara Khaleel
Sara Khaleel
DADr. Tariq Al-Qirim
Dr. Tariq Al-Qirim
AAAla Alhusban
Ala Alhusban
TATalal Ahmad Aburjai
Talal Ahmad Aburjai
TKThaqif El Khassawna
Thaqif El Khassawna
Plant-derived compounds exhibit well-documented osteogenic and anti-resorptive activities; however, their translation into consistent skeletal benefits remains limited. This review proposes a transformation-state-dependent framework in which the efficacy of plant-based interventions is interpreted through the exposure architectures they generate rather than solely through intrinsic molecular activity. By integrating plant matrix organization, gastrointestinal processing, microbial biotransformation, and formulation-driven pharmacokinetics with the temporal dynamics of bone remodeling, the review addresses a critical gap in the current literature, which largely evaluates phytochemicals independent of their delivery context. Across a continuum ranging from intact plant matrices to isolated compounds and advanced delivery systems, distinct pharmacokinetic regimes emerge, characterized by differences in release kinetics, metabolic transformation, systemic persistence, and target-site exposure. Representative interventions showing promising pharmacokinetic and skeletal findings include curcumin phytosome systems, resveratrol nanoformulations, icariin-loaded delivery platforms, and matrix-associated polyphenol systems capable of promoting sustained or metabolite-mediated exposure. Evidence indicates that sustained, metabolite-mediated exposure profiles are more compatible with the prolonged, cumulative nature of bone remodeling, whereas transient exposure often limits efficacy despite mechanistic activity. Formulation strategies, including phospholipid complexes, bioenhancers, and nano- or vesicle-based systems, can partially overcome these limitations by modulating exposure behavior. By reframing plant-based interventions as dynamic exposure systems, this framework provides a unifying basis for interpreting variability across studies and offers a rational foundation for designing strategies that align pharmacokinetic behavior with skeletal biology, thereby improving translational potential.

14 May 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
SKSara Khaleel
Sara Khaleel
DADr. Tariq Al-Qirim
Dr. Tariq Al-Qirim
AAAla Alhusban
Ala Alhusban
TATalal Ahmad Aburjai
Talal Ahmad Aburjai
TKThaqif El Khassawna
Thaqif El Khassawna
Plant-derived compounds exhibit well-documented osteogenic and anti-resorptive activities; however, their translation into consistent skeletal benefits remains limited. This review proposes a transformation-state–dependent framework in which the efficacy of plant-based interventions is interpreted through the exposure architectures they generate rather than solely through intrinsic molecular activity. By integrating plant matrix organization, gastrointestinal processing, microbial biotransformation, and formulation-driven pharmacokinetics with the temporal dynamics of bone remodeling, the review addresses a critical gap in current literature, which largely evaluates phytochemicals independent of their delivery context. Across a continuum ranging from intact plant matrices to isolated compounds and advanced delivery systems, distinct pharmacokinetic regimes emerge, characterized by differences in release kinetics, metabolic transformation, systemic persistence, and target-site exposure. Evidence indicates that sustained, metabolite-mediated exposure profiles are more compatible with the prolonged, cumulative nature of bone remodeling, whereas transient exposure often limits efficacy despite mechanistic activity. Formulation strategies, including phospholipid complexes, bioenhancers, and nano- or vesicle-based systems, can partially overcome these limitations by modulating exposure behavior. By reframing plant-based interventions as dynamic exposure systems, this framework provides a unifying basis for interpreting variability across studies and offers a rational foundation for designing strategies that align pharmacokinetic behavior with skeletal biology, thereby improving translational potential.

18 June 2026 in Diseases
Verified
Journal Article
Open access
PDF file
AKanas khaleel
anas khaleel
SKSara Khaleel
Sara Khaleel
RARuqaya Mohammed Ahmed
Ruqaya Mohammed Ahmed
AAAhmad Al Athamneh
Ahmad Al Athamneh
NENour Elsahoryi
Nour Elsahoryi
AAAhmed S.A. Ali Agha
Ahmed S.A. Ali Agha
Background/Objectives: Liposarcoma is a heterogeneous soft tissue sarcoma in which anthracycline-based chemotherapy, including doxorubicin, remains a cornerstone of treatment for advanced disease. However, variable and often limited therapeutic responses highlight the need for improved understanding of disease-associated transcriptional adaptation under chemotherapeutic stress. In this study, a bioinformatics-driven transcriptomic analysis was performed to characterize gene expression alterations associated with doxorubicin treatment in liposarcoma using publicly available data from the Gene Expression Omnibus (GSE12972). Results: Differential expression analysis identified 365 significantly altered genes, including 164 upregulated and 201 downregulated transcripts in treated samples compared with untreated controls. Functional interpretation using Ingenuity Pathway Analysis identified transforming growth factor beta 1 (TGFB1), tumor necrosis factor (TNF), and SMARCA4 as prominent predicted upstream regulators associated with transcriptional programs related to extracellular matrix remodeling, inflammatory and immune modulation, epithelial-to-mesenchymal transition-like states, and chromatin-mediated transcriptional plasticity. Enriched canonical pathways included Liposarcoma tumor microenvironment-associated signaling and fibrosis-related pathways, reflecting stromal activation and immune-related transcriptional changes. Notably, fibroblast growth factor 1 (FGF1) emerged as a supportive regulatory node linked to survival- and anti-apoptotic gene expression patterns. Conclusions: Collectively, these findings provide a disease-oriented, cross-subtype systems-level view of the transcriptional changes associated with doxorubicin treatment in liposarcoma. This work is intended as a hypothesis-generating framework that may inform future functional studies and integrative approaches aimed at understanding therapeutic response and disease progression.